Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.8 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.1.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
C.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.2 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used